Prospective Phase III validation for EndoPredict – Read more

Updated ESMO Guidelines 2024

February 26, 2024

Level of Evidence (LoE) 1A for all gene expression assays in early ER+ HER2- breast cancer We are pleased to share the latest insights from the ESMO Clinica...

Continue Reading